Company Short-Term Debts: Monogram Technologies (MGRM)

Monogram Orthopedics Inc. (MGRM) - corporate logo

The price history of Monogram Technologies (MGRM) reflects the dynamics of a company implementing robotic solutions in orthopedics. The current metric stands at 0.00. The business relies on personalized 3D implants and precision milling to improve joint integration. The enterprise is currently actively expanding its network of hospital clients, offering innovative tooling during the large-scale commercial rollout of its technologies.

MGRM (Monogram Orthopedics) Company Short-Term Debts history from 02/21/2024 to 10/18/2025

Summary analytical data breakdowns for Monogram Orthopedics Inc. (MGRM)

- price and consensus price forecast:
Stock Price Monogram Orthopedics|MGRM - Analyst Median Target
- market capitalization data:
Market Capitalization Monogram Technologies|MGRM - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Monogram Orthopedics|MGRM - Book Capitalization|Market Value to Book Value Ratio monogramorthopedics.com|MGRM - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Monogram Technologies|MGRM - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Monogram Technologies|MGRM - Company Total Debt Obligations|Debt to Book Capitalization Ratio Monogram Technologies|MGRM - Company Long-Term Indebtedness|Company Short-Term Debt Monogram Orthopedics
Fundamental company valuation:Monogram Technologies
Signature product of Monogram Orthopedics Inc.

Short-term debts reflect obligations with maturities of up to one year, determining the risk of insolvency during market volatility. For Monogram Technologies (MGRM), this parameter is critical, as maintaining a staff of high-paid roboticists requires a stable cash flow. By analyzing the company's short-term debts, an investor assesses the resilience of the high-tech firm's operating cycle. An increase in this metric signals a potential liquidity shortage. Monitoring this indicator minimizes the risk of capital losses.

Competitor analysis for Monogram Technologies

Company Short-Term Debts ISRG (Intuitive)|DHR - Short-Term Debt Volume|BDX (Becton, Dickinson and Company) - Company Short-Term Debts|STERIS Group (STE) - Company Current Liabilities|WST (West Pharmaceutical Services) - Company Short-Term Debts|Company Short-Term Debts BAX|Company Short-Term Debt Masimo (MASI)|Company Short-Term Debt Stevanato Group SpA STVN|Company Current Liabilities Teleflex Inc|Company Short-Term Loans and Borrowings Merit Medical Corp MMSI|Company Short-Term Debts NVST (Envista Holdings)|ICUI: Short-Term Debt Volume|Company Short-Term Debt Dentsply Sirona|LMAT (LeMaitre Vascular Inc) - Company Short-Term Indebtedness|ATRC: Company Short-Term Debt|Short-Term Debt Volume STAAR Surgical Co (STAA)|Company Current Liabilities ChromaDex|Amount of Current Liabilities ZIMV (zimvie.com)|Company Short-Term Debt AngioDynamics|CERS - Company Short-Term Loans and Borrowings|Alpha Teknova Inc - Company Current Liabilities|STSS: Company Short-Term Debts|INFU (infusystem.com) - Company Short-Term Debt|utahmed.com (UTMD) - Company Current Liabilities|Company Short-Term Debts KRMD (KORU Medical Systems, Inc.)|Short-Term Debt NYXH|Company Short-Term Debt Microbot Medical Inc MBOT|Company Short-Term Indebtedness Pro-Dex Inc. PDEX|Company Current Liabilities Zentek Ltd. (ZTEK)|elutia.com - Amount of Current Liabilities|Company Short-Term Debt MLSS (Milestone Scientific Inc.)|NXGL: Short-Term Debt Volume|RVP (retractable.com) - Company Short-Term Debt|HBIO (Harvard Bioscience Inc.) - Company Current Liabilities|Company Short-Term Debt FEMY (Femasys Inc.)|Short-Term Debt MHUA|Company Short-Term Debt Predictive Oncology POAI|Company Short-Term Indebtedness CJMB (callanjmb.com)|ATRI: Company Short-Term Debt|Short-Term Debt NeuroMetrix Corporation NURO